Pearce Samantha 4

What Happened
Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals (JAZZ), had 2,527 ordinary shares withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding was recorded at $237.72 per share, for a total value of approximately $600,718. This is a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date: 2026-06-30
• Price used for withholding: $237.72 per share
• Shares withheld/disposed: 2,527 shares — total value ≈ $600,718
• Footnote F1: Withheld shares to satisfy tax obligations on vested RSUs (net settlement).
• Footnote F2: Reporting person also acquired 166 shares under a Section 423 Employee Stock Purchase Plan on 2026-05-29.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing date: 2026-07-02 — appears timely (no late-file flag indicated).

Context
Tax-withholding on RSU vesting is a routine internal transaction that reduces the insider's reported shares to cover taxes; it should not be interpreted as a discretionary open-market sale signaling a change in sentiment. For investors, purchases (including ESPP buys noted in F2) generally carry clearer signaling value than routine withholding events.